Literature DB >> 24605830

Gender-specific roles for the melanocortin-3 receptor in the regulation of the mesolimbic dopamine system in mice.

Rachel N Lippert1, Kate L J Ellacott, Roger D Cone.   

Abstract

The melanocortin-3 receptor (MC3R) and MC4R are known to play critical roles in energy homeostasis. However, the physiological functions of the MC3R remain poorly understood. Earlier reports indicated that the ventral tegmental area (VTA) is one of the highest sites of MC3R expression, and we sought to determine the function of the receptor in this brain region. A MC3R-green-fluorescent protein transgenic mouse and a MC3R knockout mouse strain were used to characterize the neurochemical identity of the MC3R neurons in the VTA and to determine the effects of global MC3R deletion on VTA dopamine (DA) homeostasis. We demonstrate that the MC3R, but not MC4R, is expressed in up to a third of dopaminergic neurons of the VTA. Global deletion of the MC3R increases total dopamine by 42% in the VTA and decreases sucrose intake and preference in female but not male mice. Ovariectomy restores dopamine levels to normal, but aberrant decreased VTA dopamine levels are also observed in prepubertal female mice. Because arcuate Agouti-related peptide/neuropeptide Y neurons are known to innervate and regulate VTA signaling, the MC3R in dopaminergic neurons provides a specific input for communication of nutritional state within the mesolimbic dopamine system. Data provided here suggest that this input may be highly sexually dimorphic, functioning as a specific circuit regulating effects of estrogen on VTA dopamine levels and on sucrose preference. Overall, this data support a sexually dimorphic function of MC3R in regulation of the mesolimbic dopaminergic system and reward.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24605830      PMCID: PMC3990839          DOI: 10.1210/en.2013-2049

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  33 in total

Review 1.  Anatomy and regulation of the central melanocortin system.

Authors:  Roger D Cone
Journal:  Nat Neurosci       Date:  2005-05       Impact factor: 24.884

2.  Selective dopaminergic lesions of the ventral tegmental area impair preference for sucrose but not for male sexual pheromones in female mice.

Authors:  José Martínez-Hernández; Enrique Lanuza; Fernando Martínez-García
Journal:  Eur J Neurosci       Date:  2006-08       Impact factor: 3.386

3.  Evaluation of behavioural effects of neural melanocortin receptor antagonists injected ICV and in VTA in rats.

Authors:  V Klusa; S Svirskis; B Opmane; R Muceniece; A Skujins; F Mutulis; J E Wikberg; H B Schiöth
Journal:  Neuropeptides       Date:  1998-12       Impact factor: 3.286

4.  Blockade of melanocortin transmission inhibits cocaine reward.

Authors:  Richard Hsu; Jane R Taylor; Samuel S Newton; John D Alvaro; Colin Haile; G Han; Victor J Hruby; Eric J Nestler; Ronald S Duman
Journal:  Eur J Neurosci       Date:  2005-04       Impact factor: 3.386

5.  Effect of estrogen on melanocortin-3 receptor mRNA expression in mouse pituitary glands in vivo and in vitro.

Authors:  Ryusei Matsumura; Sakae Takeuchi; Sumio Takahashi
Journal:  Neuroendocrinology       Date:  2004-11-30       Impact factor: 4.914

6.  Bilateral dopaminergic lesions in the ventral tegmental area of rats influence sucrose intake, but not umami and amino acid intake.

Authors:  Ryoko Shibata; Makiko Kameishi; Takashi Kondoh; Kunio Torii
Journal:  Physiol Behav       Date:  2009-01-13

7.  Sex-specific programming of offspring emotionality after stress early in pregnancy.

Authors:  Bridget R Mueller; Tracy L Bale
Journal:  J Neurosci       Date:  2008-09-03       Impact factor: 6.167

8.  Repeated agouti related peptide (83-132) injections inhibit cocaine-induced locomotor sensitisation, but not via the nucleus accumbens.

Authors:  Edwin Alserda; Roger A H Adan; Geert M J Ramakers
Journal:  Eur J Pharmacol       Date:  2013-07-19       Impact factor: 4.432

9.  Identification of a receptor for gamma melanotropin and other proopiomelanocortin peptides in the hypothalamus and limbic system.

Authors:  L Roselli-Rehfuss; K G Mountjoy; L S Robbins; M T Mortrud; M J Low; J B Tatro; M L Entwistle; R B Simerly; R D Cone
Journal:  Proc Natl Acad Sci U S A       Date:  1993-10-01       Impact factor: 11.205

10.  Obesity-induced inflammation in white adipose tissue is attenuated by loss of melanocortin-3 receptor signaling.

Authors:  Kate L J Ellacott; Jonathan G Murphy; Daniel L Marks; Roger D Cone
Journal:  Endocrinology       Date:  2007-09-27       Impact factor: 4.736

View more
  34 in total

1.  Cross interaction of melanocortinergic and dopaminergic systems in neural modulation.

Authors:  Zhi-Gang He; Bao-Wen Liu; Hong-Bing Xiang
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2015-12-13

2.  Evidence that Melanocortin Receptor Agonist Melanotan-II Synergistically Augments the Ability of Naltrexone to Blunt Binge-Like Ethanol Intake in Male C57BL/6J Mice.

Authors:  Montserrat Navarro; Francisca Carvajal; Jose Manuel Lerma-Cabrera; Inmaculada Cubero; Mitchell J Picker; Todd E Thiele
Journal:  Alcohol Clin Exp Res       Date:  2015-06-24       Impact factor: 3.455

Review 3.  Cognitive and autonomic determinants of energy homeostasis in obesity.

Authors:  Denis Richard
Journal:  Nat Rev Endocrinol       Date:  2015-06-30       Impact factor: 43.330

4.  Discovery of Polypharmacological Melanocortin-3 and -4 Receptor Probes and Identification of a 100-Fold Selective nM MC3R Agonist versus a μM MC4R Partial Agonist.

Authors:  Katlyn A Fleming; Katie T Freeman; Mike D Powers; Radleigh G Santos; Ginamarie Debevec; Marc A Giulianotti; Richard A Houghten; Skye R Doering; Clemencia Pinilla; Carrie Haskell-Luevano
Journal:  J Med Chem       Date:  2019-02-28       Impact factor: 7.446

5.  MC4R expression in pedunculopontine nucleus involved in the modulation of midbrain dopamine system.

Authors:  Yan Hao; Xue-Bi Tian; Tao-Tao Liu; Cheng Liu; Hong-Bing Xiang; Jian-Guo Zhang
Journal:  Int J Clin Exp Pathol       Date:  2015-02-01

6.  Decreased consumption of rewarding sucrose solutions after injection of melanocortins into the ventral tegmental area of rats.

Authors:  Haw-Han Yen; Aaron G Roseberry
Journal:  Psychopharmacology (Berl)       Date:  2014-07-03       Impact factor: 4.530

Review 7.  The melanocortin pathway and control of appetite-progress and therapeutic implications.

Authors:  Giulia Baldini; Kevin D Phelan
Journal:  J Endocrinol       Date:  2019-04-01       Impact factor: 4.286

8.  Altered sucrose self-administration following injection of melanocortin receptor agonists and antagonists into the ventral tegmental area.

Authors:  Laranci Shanmugarajah; Anna I Dunigan; Kyle J Frantz; Aaron G Roseberry
Journal:  Psychopharmacology (Berl)       Date:  2017-02-27       Impact factor: 4.530

9.  Alpha-melanocyte stimulating hormone increases the activity of melanocortin-3 receptor-expressing neurons in the ventral tegmental area.

Authors:  Katherine Stuhrman West; Chunxia Lu; David P Olson; Aaron G Roseberry
Journal:  J Physiol       Date:  2019-05-26       Impact factor: 5.182

Review 10.  60 YEARS OF POMC: Regulation of feeding and energy homeostasis by α-MSH.

Authors:  Erica J P Anderson; Isin Çakir; Sheridan J Carrington; Roger D Cone; Masoud Ghamari-Langroudi; Taneisha Gillyard; Luis E Gimenez; Michael J Litt
Journal:  J Mol Endocrinol       Date:  2016-03-03       Impact factor: 5.098

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.